Science Explorer Back to mapMap
Discussion
Researcher · Sarah Cannon · United States

Melissa Lynne Johnson

Melissa Lynne Johnson publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, on topics such as Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers and Lung Cancer Research Studies.

ORCID 0000-0001-9874-1314 OpenAlex
World rank
#30,657
of 7,710,434 ranked researchers
Rank in United States
#11,608
of 1,627,098
Works
868
Citations
26k
Citations per work
29.6
h-index
68
i10-index 226Top 1.5% in Oncology

What does Melissa Lynne Johnson research?

Melissa Lynne Johnson's work is mostly in Medicine (67%), Biochemistry, Genetics and Molecular Biology (15%), Immunology and Microbiology (5%).

Life Sciences20%Health Sciences67%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine57966.7%
    1. Biochemistry, Genetics and Molecular Biology12714.6%
    2. Immunology and Microbiology455.2%
  1. Everything else11713.5%
  1. 1Oncology40% of their works
  2. 2Pulmonary and Respiratory Medicine21% of their works
  3. 3Molecular Biology11% of their works
  4. 4Radiology, Nuclear Medicine and Imaging6% of their works
  5. 5Immunology5% of their works
  6. 6Cancer Research4% of their works

Research topics

Which keywords describe Melissa Lynne Johnson's research?

The keywords of their largest research topics: Targeted Therapy, Clinical Trials, Chemotherapy, Immunotherapy, ALK Inhibitors, EGFR Mutations, Immune Checkpoint Blockade and PD-1 and PD-L1.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Targeted Therapy3923 topics
  2. Clinical Trials3422 topics
  3. Chemotherapy2443 topics
  4. Immunotherapy2162 topics
  5. ALK Inhibitors2061 topic
  6. EGFR Mutations2061 topic
  7. Immune Checkpoint Blockade1671 topic
  8. PD-1 and PD-L11671 topic
  9. Genomic Profiles1361 topic
  10. Small-Cell Lung Cancer1361 topic
  11. Cancer Immunotherapy1282 topics
  12. CAR T Cells801 topic
  13. Chimeric Antigen Receptor801 topic
  14. CT Screening561 topic
  15. Lung Cancer561 topic
  16. Cetuximab521 topic
  17. KRAS Mutations521 topic
  18. Cancer Genomics501 topic
  19. Mutational Signatures501 topic
  20. Dendritic Cells481 topic
  21. Immunity481 topic

Where does Melissa Lynne Johnson work?

Melissa Lynne Johnson's main affiliation in the publication record is Sarah Cannon, United States.

How many publications and citations does Melissa Lynne Johnson have?

OpenAlex counts 868 works and 25,700 citations for Melissa Lynne Johnson, an h-index of 68, ranking #30,657 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Melissa Lynne Johnson. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.